Persistent B Cell Depletion After Rituximab for Autoimmune and Glomerular Diseases: A Case Series
Persistent B cell depletion is a rare complication of rituximab treatment, mostly affecting patients with exposure(s) to cytotoxic therapies for recurrent diseases. It is characterized by prolonged disease remission and increased infection risk.
Authors
- Anushya Jeyabalan (ORCID: https://orcid.org/0000-0003-1959-0250)
- John L. Niles (ORCID: https://orcid.org/0009-0003-4072-6535)
- Reza Zonozi (ORCID: https://orcid.org/0000-0002-7389-4549)
- Katherine Cosgrove (ORCID: https://orcid.org/0009-0009-4238-2581)
- Orhan Efe (ORCID: https://orcid.org/0000-0003-4852-9061)
- Frank B. Cortazar (ORCID: https://orcid.org/0000-0003-4532-5039)
- Gabriel Sauvage (ORCID: https://orcid.org/0000-0001-9485-491X)
- Karen Laliberte (ORCID: https://orcid.org/0009-0003-0223-2796)
- Ayman Al Jurdi (ORCID: https://orcid.org/0000-0002-7652-3399)
- Harish Seethapathy (ORCID: https://orcid.org/0000-0002-1171-1022)
Institutions
- Harvard University (US)
- Inova Fairfax Hospital (US)
- Massachusetts General Hospital (US)
- St Peter's Hospital (US)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1016/j.ekir.2025.02.002
- Citations
- 6
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 9.11